Suppr超能文献

[术前化疗和放疗对373例儿童肾母细胞瘤的重要性]

[The importance of preoperative chemotherapy and radiotherapy in 373 children with Wilms' tumor].

作者信息

Gutjahr P, Schwenger M, Spaar H J, Michaelis J, Niethammer D, Jürgens H, Kühl J, Ludwig R, Kutzner J, Schmidt D

机构信息

Universitätskinderkliniken Mainz, Tübingen.

出版信息

Dtsch Med Wochenschr. 1990 Feb 16;115(7):248-53. doi: 10.1055/s-2008-1065000.

Abstract

Between 1980 and 1988, in a prospective study of 373 children with Wilms' tumour throughout the Federal Republic of Germany, the results of various pre- and postoperative treatment schedules were analysed. There were 184 boys and 189 girls, mean age 3 11/12 (0-27) years. One third each was in group I, II or III-V, respectively. In 52% of cases the tumour volume, measured by ultrasound, was more than 400 ml. 218 of the children were called protocol patients, the remaining 155 served as observation patients, because the latter had histological variants or there had been marked treatment deviations. The stage-adapted treatment always included operation, in 30% of children after pre-operative chemo- or radiotherapy. Radiotherapy was given in selected patients in stage II and always to those in stages III, IV or V. Chemotherapy consisted of Actinomycin D and vincristine, adriamycin was added for stages III-V and cyclophosphamide or ifosfamide for histologically highly malignant variants. Of the 218 protocol patients 196 (90%) were alive without recurrence, after a mean observation time of more than 7 years. Radiotherapy was given to only 105 of the 218 protocol patients. The prognosis of the 155 observation patients differed according to the histology: those with clear-cell type had a better prognosis than previously reported. Among the total group of 373 patients 305 (81.8%) have remained without recurrence after more than 6 years.

摘要

1980年至1988年期间,在对德意志联邦共和国全境373例威尔姆斯瘤患儿进行的一项前瞻性研究中,分析了各种术前和术后治疗方案的结果。其中男孩184例,女孩189例,平均年龄3岁11个月(0 - 27岁)。分别有三分之一的患儿属于I组、II组或III - V组。52%的病例经超声测量肿瘤体积超过400毫升。218名患儿被称为方案患者,其余155名作为观察患者,因为后者存在组织学变异或有明显的治疗偏差。根据分期的治疗总是包括手术,30%的患儿在术前进行化疗或放疗后再手术。II期的部分患者接受放疗,III、IV或V期的患者则总是接受放疗。化疗药物包括放线菌素D和长春新碱,III - V期加用阿霉素,组织学高度恶性变异型加用环磷酰胺或异环磷酰胺。218例方案患者中,196例(90%)存活且无复发,平均观察时间超过7年。218例方案患者中只有105例接受了放疗。155例观察患者的预后因组织学类型而异:透明细胞型患者的预后比之前报道的要好。在373例患者的总体中,305例(81.8%)在6年多后仍无复发。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验